| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.52 | 0.07 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.07 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.07 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |